Barbara Freischem is Executive Director of the European Biopharmaceutical Enterprises (EBE), since July 2015. EBE is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing biopharmaceutical companies of all sizes.
Barbara has worked at national, European and international level. Starting out on the side of regulatory authorities, her career spans working in the pharmaceutical industry, industry associations as well as in an international intergovernmental organisation.
Barbara, a German national, holds a degree in veterinary medicine from the Free University of Berlin.